TMPRSS2 and COVID-19: At the same time, it might also be worthy to continue investigating the utility of viral entry inhibitors as potential treatment for COVID-19 by focusing on other TMPRSS2 inhibitors with greater pharmacological potency, agents with TMPRSS2-independent activity, or effective synergistic combinations of both.